tiprankstipranks
Trending News
More News >
SkinBioTherapeutics plc (GB:SBTX)
:SBTX
Advertisement

SkinBioTherapeutics (SBTX) Revenue

Compare
18 Followers

SkinBioTherapeutics Revenue

SkinBioTherapeutics had a revenue of 1.58M in the quarter ending Dec 31, 2024, with 43.10%. This bring the company's revenue in the last twelve months to 2.68M, Decreased 121.67%. In the fiscal year ending Jun 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M with 815.51% growth.
Revenue (ttm)
2.68M
Revenue Growth
1557.07%
P/S Ratio
35.32
Revenue/Employee
£80,600
Employees
15
Market Cap
£42.70M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
1.21M1.08M+815.51%
Jun 30, 2023
132.06K57.30K+76.64%
Jun 30, 2022
74.76K+∞%
Jun 30, 2021
0.00
Jun 30, 2020
0.00
Jun 30, 2019
0.00
Jun 30, 2018
0.00
Jun 30, 2017
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis